Maven Capital Partners (Maven) has exited its investment in Westfield Medical Group Limited (Westfield) via a trade sale to France domiciled Sterimed Group which generated a 2.2x blended return for investors.
UK-based Westfield is a provider of single use sterilisation barrier packaging and other sterilisation products to the public and private healthcare and industrial sectors. Its customers include NHS hospital sterile departments, private hospitals, industrial and medical device manufacturers.
Maven led the management buyout of Westfield in 2016, funded through Maven’s co-investment network for professional clients ‘Maven Investor Partners’. With the investment and support provided by Maven, the business has expanded in the UK and grown its international footprint, with sales into EMEA, Asia and the Americas accounting for over 45 per cent of 2020 revenues.
